The US Patent Office has opened a review of patents and patent applications concerning CRISPR technology. The legal process could result in rights being transferred between the disputing parties, The US Patent Office ), Berkeley and The Patent Office , Berkeley . The Patent Office previously ruled that the Broad Institute's achievement of making the University of California (UC work inside human cells was a separate invention to that of The US Patent Office , which first achieved gene-editing in a test tube. The ruling enabled Broad to retain its key patents. However, it also led to additional challenges regarding other rights.
The US Patent Office has opened a review of patents and patent applications concerning CRISPR technology. The legal process could result in rights being transferred between the disputing parties, the University of California (UC), Berkeley and the Broad Institute of Cambridge, Massachusetts. The Patent Office previously ruled that the Broad Institute's achievement of making CRISPR work inside human cells was a separate invention to that of UC Berkeley, which first achieved gene-editing in a test tube. The ruling enabled Broad to retain its key patents. However, it also led to additional challenges regarding other rights.